ArticleThe breast journal2026

HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0.

Anushree R Iyengar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.